Visceral fat accumulation, insulin resistance, and elevated depressive symptoms in middle-aged Japanese men

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  Yamamoto, Shuichiro ^a   Matsushita, Yumi ^b   Nakagawa, Toru ^a   Honda, Toru ^a   Hayashi, Takeshi ^a   Noda, Mitsuhiko ^c   Mizoue, Tetsuya ^b  

^a HITACHI LTD   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; BIOLOGICAL MARKER; GLUCOSE;

ABDOMINAL RADIOGRAPHY; ADULT; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE MARKER; HUMAN; INSULIN RESISTANCE; INTRAABDOMINAL FAT; JAPANESE (PEOPLE); LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; SUBCUTANEOUS FAT; ABDOMINAL OBESITY; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; COMPLICATION; HEALTH SURVEY; JAPAN; METABOLISM; MIDDLE AGED; OBESITY; QUESTIONNAIRE; RISK FACTOR;

ADIPOSITY; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOMARKERS; DEPRESSION; GLUCOSE; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; JAPAN; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; PUBLIC HEALTH SURVEILLANCE; RISK FACTORS; SURVEYS AND QUESTIONNAIRES;

EID: 84960540297     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0149436     Document Type: Article

References (44)

1. Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 2000; 23: 934-942. PMID: 10895843
2. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001; 24: 1069-1078. PMID: 11375373
3. Talbot F, Nouwen A. A review of the relationship between depression and diabetes in adults: is there a link? Diabetes Care 2000; 23: 1556-1562. PMID: 11023152
4. Kivimäki M, Lawlor DA, Singh-Manoux A, Batty GD, Ferrie JE, Shipley MJ, et al. Common mental disorder and obesity: insight from four repeat measures over 19years: prospective Whitehall II cohort study. BMJ 2009; 339: b3765. doi: 10.1136/bmj.b3765 PMID: 19808765
5. Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BW, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 2010; 67: 220-229. doi: 10.1001/archgenpsychiatry.2010.2 PMID: 20194822
6. Golden SH, Lazo M, Carnethon M, Bertoni AG, Schreiner PJ, Diez Roux AV, et al. Examining a bidirectional association between depressive symptoms and diabetes. JAMA 2008; 299: 2751-2759. doi: 10.1001/jama.299.23.2751 PMID: 18560002
7. de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med 2001; 63: 619-630. PMID: 11485116
8. Katon WJ, Rutter C, Simon G, Lin EH, Ludman E, Ciechanowski P, et al. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 2005; 28: 2668-2672. PMID: 16249537
9. Yokoyama K, Yamada T, Mitani H, Yamada S, Pu S, Yamanashi T, et al. Relationship between hypothalamic-pituitary-adrenal axis dysregulation and insulin resistance in elderly patients with depression. Psychiatry Res 2015; 226: 494-498. doi: 10.1016/j.psychres.2015.01.026 PMID: 25757913
10. Miller GE, Stetler CA, Carney RM, Freedland KE, Banks WA. Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 2002; 90: 1279-1283. PMID: 12480034
11. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160: 2101-2107. PMID: 10904452
12. Lovell GP, Nash K, Sharman R, Lane BR. Across-sectional investigation of depressive, anxiety, and stress symptoms and health-behavior participation in Australian university students. Nurs Health Sci 2015; 17: 134-142.
13. Masand PS, Gupta S. Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine. Ann Clin Psychiatry 2002; 14: 175-182. PMID: 12585567
14. Herva A, Laitinen J, Miettunen J, Veijola J, Karvonen JT, Läksy K, et al. Obesity and depression: results from the longitudinal Northern Finland 1966 Birth Cohort Study. Int J Obes 2006; 30: 520-527.
15. Zhao G, Ford ES, Li C, Tsai J, Dhingra S, Balluz LS. Waist circumference, abdominal obesity, and depression among overweight and obese U.S. adults: National Health and Nutrition Examination Survey 2005-2006. BMC Psychiatry 2011; 11: 130. doi: 10.1186/1471-244X-11-130 PMID: 21834955
16. Rivenes AC, Harvey SB, Mykletun A. The relationship between abdominal fat, obesity, and common mental disorders: results from the HUNT study. J Psychosom Res 2009; 66: 269-275. doi: 10.1016/j.jpsychores.2008.07.012 PMID: 19302883
17. Thakore JH, Richards PJ, Reznek RH, Martin A, Dinan TG. Increased intra-abdominal fat deposition in patients with major depressive illness as measured by computed tomography. Biol Psychiatry 1997; 41: 1140-1142. PMID: 9146826
18. Kahl KG, Bester M, Greggersen W, Rudolf S, Dibbelt L, Stoeckelhuber BM, et al. Visceral fat deposition and insulin sensitivity in depressed women with and without comorbid borderline personality disorder. Psychosom Med 2005; 67: 407-412. PMID: 15911903
19. Everson-Rose SA, Lewis TT, Karavolos K, Dugan SA, Wesley D, Powell LH. Depressive symptoms and increased visceral fat in middle-aged women. Psychosom Med 2009; 71: 410-416. doi: 10.1097/PSY.0b013e3181a20c9c PMID: 19398501
20. Murabito JM, Massaro JM, Clifford B, Hoffmann U, Fox CS. Depressive symptoms are associated with visceral adiposity in a community-based sample of middle-aged women and men. Obesity (Silver Spring) 2013; 21: 1713-1719.
21. Vogelzangs N, Kritchevsky SB, Beekman AT, Brenes GA, Newman AB, Satterfield S, et al. Obesity and onset of significant depressive symptoms: results from a prospective community-based cohort study of older men and women. J Clin Psychiatry 2010; 71: 391-399. doi: 10.4088/JCP.08m04743blu PMID: 20021992
22. Remigio-Baker RA, Allison MA, Schreiner PJ, Szklo M, Crum RM, Leoutsakos JM, et al. Difference by sex but not by race/ethnicity in the visceral adipose tissue-depressive symptoms association: the Multi Ethnic Study of Atherosclerosis. Psychoneuroendocrinology 2014; 47: 78-87. doi: 10.1016/j.psyneuen.2014.05.004 PMID: 25001957
23. Kadowaki T, Sekikawa A, Murata K, Maegawa H, Takamiya T, Okamura T, et al. Japanese men have larger areas of visceral adipose tissue than Caucasian men in the same levels of waist circumference in a population-based study. Int J Obes (Lond) 2006; 30: 1163-1165
24. Kan C, Silva N, Golden SH, Rajala U, Timonen M, Stahl D, et al. A systematic review and meta-analysis of the association between depression and insulin resistance. Diabetes Care 2013; 36: 480-489. doi: 10.2337/dc12-1442 PMID: 23349152
25. Matsushita Y, Nakagawa T, Yamamoto S, Takahashi Y, Yokoyama T, Noda M, et al. Associations of visceral and subcutaneous fat areas with the prevalence of metabolic riskfactor clustering in 6,292 Japanese individuals: the Hitachi Health Study. Diabetes Care 2010; 33: 2117-2119. doi: 10.2337/dc10-0120 PMID: 20460443
26. Yamamoto S, Matsushita Y, Nakagawa T, Hayashi T, Noda M, Mizoue T. Circulating adiponectin levels and risk of type 2 diabetes in the Japanese. Nutr Diabetes 2014; 4: e130. doi: 10.1038/nutd.2014.27 PMID: 25133442
27. Yakura N. Verification of the Validity of Depressive Symptom Scale. Based on the Existing Health Questionnaire. Asian Pac J Dis Manage 2009; 3: 21-26.
28. Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E et al. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Investig 2010; 1: 212-228. doi: 10.1111/j.2040-1124.2010.00074.x PMID: 24843435
29. Hsieh CJ, Wang PW, Chen TY. The relationship between regional abdominal fat distribution and both insulin resistance and subclinical chronic inflammation in non-diabetic adults. Diabetol Metab Syndr 2014; 6: 49. doi: 10.1186/1758-5996-6-49 PMID: 24684833
30. Preis SR, Massaro JM, Robins SJ, Hoffmann U, Vasan RS, Irlbeck T, et al. Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study. Obesity (Silver Spring) 2010; 18: 2191-2198.
31. Pearson S, Schmidt M, Patton G, Dwyer T, Blizzard L, Otahal P, et al. Depression and insulin resistance: cross-sectional associations in young adults. Diabetes Care 2010; 33: 1128-1133. doi: 10.2337/dc09-1940 PMID: 20185745
32. Pyykkönen AJ, Räikkönen K, Tuomi T, Eriksson JG, Groop L, Isomaa B. Depressive symptoms, antidepressant medication use, and insulin resistance: the PPP-Botnia Study. Diabetes Care 2011; 34: 2545-2547. doi: 10.2337/dc11-0107 PMID: 21953801
33. Lawlor DA, Ben-Shlomo Y, Ebrahim S, Davey Smith G, Stansfeld SA, Yarnell JW, et al. Insulin resistance and depressive symptoms in middle aged men: findings from the Caerphilly prospective cohort study. BMJ 2005; 330: 705-706. PMID: 15684022
34. Roos C, Lidfeldt J, Agardh CD, Nyberg P, Nerbrand C, Samsioe G, et al. Insulin resistance and selfrated symptoms of depression in Swedish women with risk factors for diabetes: the Women's Health in the Lund Area study. Metabolism 2007; 56: 825-829. PMID: 17512316
35. Rebuffé-Scrive M, Brönnegard M, Nilsson A, Eldh J, Gustafsson JA, Björntorp P. Steroid hormone receptors in human adipose tissues. J Clin Endocrinol Metab 1990; 71: 1215-1219. PMID: 2229280
36. Pedersen SB, Jønler M, Richelsen B. Characterization of regional and gender differences in glucocorticoid receptors and lipoprotein lipase activity in human adipose tissue. J Clin Endocrinol Metab 1994; 78: 1354-1359. PMID: 8200937
37. Cohen S, Janicki-Deverts D, Doyle WJ, Miller GE, Frank E, Rabin BS, et al. Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. Proc Natl Acad Sci USA 2012; 109: 5995-5999. doi: 10.1073/pnas.1118355109 PMID: 22474371
38. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006; 116: 1793-1801. PMID: 16823477
39. Engström G, Hedblad B, Stavenow L, Lind P, Janzon L, Lindgärde F. Inflammation-sensitive plasma proteins are associated with future weight gain. Diabetes 2003; 52: 2097-2101. PMID: 12882928
40. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010; 67: 446-457. doi: 10.1016/j.biopsych.2009.09.033 PMID: 20015486
41. Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 2007; 132: 2169-2180. PMID: 17498510
42. Walker BR Activation of the hypothalamic-pituitary-adrenal axis in obesity: cause or consequence? Growth Horm IGF Res 2001; 11 Suppl A: S91-95. PMID: 11527096
43. Huber JD Diabetes, cognitive function, and blood-brain barrier. Curr Pharm Des 2008; 14: 1594-1600. PMID: 18673200
44. Ajilore O, Haroon E, Kumaran S, Darwin C, Binesh N, Mintz J, et al. Measurement of brain metabolites in patients with type 2 diabetes and major depression using proton magnetic resonance spectroscopy. Neuropsychopharmacology 2007; 32: 1224-1231. PMID: 17180124